2024 annual financial data
Processa Pharmaceuticals 2024 Operating margin
Processa Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -12,051,206 USD and net income was -11,850,118 USD.
Operating cash flow was -11,245,042 USD.
Get free Processa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -12,051,206 USD
- Net income
- -11,850,118 USD
- Operating cash flow
- -11,245,042 USD